Navigation Links
Microbix Signs Marketing Agreement For Kinlytic(R)(Urokinase) In Growing Middle East Region
Date:11/17/2009

Riso Pharma guarantees to purchase 50,000 KINLYTIC vials over next three years

TORONTO, Nov. 17 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX), a biotech company focused on virology and biological technologies, today announced a marketing and supply agreement with Riso Pharma that guarantees purchases of not less than 50,000 KINLYTIC vials over the next three years. KINLYTIC (Urokinase) is Microbix' thrombolytic agent for treating pulmonary embolism.

Under the terms of the agreement, Microbix will grant Riso exclusive rights to market KINLYTIC throughout the Middle East. Microbix will share in the revenues from KINLYTIC sales in all countries covered by the agreement and Riso will be responsible for all commercialization activities. Microbix expects KINLYTIC sales to commence around mid-year 2010.

Mark A. Cochran, Microbix' Chief Business Officer, said, "Microbix is off to a great start as we bring KINLYTIC back to the world's medical community. We expect to provide our clot-busting therapy to other parts of the world by signing additional agreements, such as this one, throughout 2010. And, while final pricing for our therapy has not been yet established, even at a discounted pricing offered to these emerging markets, Microbix will profit substantially from this agreement covering the Middle East."

The market for pharmaceutical sales in the Middle East is valued today at $12 billion and is expected to grow 10 to 15 percent annually, according to published pharmaceutical market reports. Growth in this region is being forecast for the pharmaceutical and biotechnology industries due to moves by Middle Eastern nations to liberalize national economies and introduce universal health care coverage.

P. Daniel Bagi, M.D., Managing Director of Riso Pharma, said, "We are very pleased to add KINLYTIC to our diverse product offerings throughout the Middle East. As with all of our product sales, we
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Microbix Biosystems Re-files Annual Results With OSC
2. Microbix Biosystems Provides a Corporate Update
3. Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility
4. Microbix Sales Grow 22% For Nine Months
5. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
6. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
7. Microbix Announces A New Technology Platform For The SST Project
8. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
9. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
10. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
11. DATATRAK Signs New Client for Rescue Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 02, 2015 Resilinc released ... report which summarizes and analyzes nearly 700 unique ... EventWatch™ 24X7 global event monitoring and alert reporting ... a free trial period of the email service to ... that can negatively impact revenue, market share, customer satisfaction, ...
(Date:3/2/2015)... , March 2, 2015 ... and healthy whole food nutrition products reveal technological ... lifestyle related disorders such as hyperglycemia, obesity, insulin ... concerns.  Nutraceutical and Biotech Companies in focus today ... Nature Foods Ltd. (NYSE: ANFI ), ...
(Date:3/2/2015)... 2015 Global Stem Cells ... with Shenzhen HANK Bioengineering Co., Ltd. and its ... will establish a stem cells training course in ... September 2015. , Shenzhen HANK is a biotechnology ... scientist, microbiologist and virologist, to integrate research, development, ...
(Date:2/27/2015)... SUMMERLAND, British Columbia , Feb. 27, 2015 ... ), a leader in synthetic biology, today announced it ... Fruits (OSF), the pioneering agricultural company behind the ... non-browning apple. Through the acquisition, Intrexon expands its food ... appetizing and convenient for consumers while providing economic benefit ...
Breaking Biology Technology:Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4
... MaxCyte, Inc., a,clinical-stage therapeutics company and pioneer ... that Anthony Recupero, Ph.D.,Vice President Business Development ... 2008, at 2:00PM at the BIO-Europe Spring ... will discuss the development of,engineered cell based ...
... continues to advance collaborative research worldwide, ... Biosystems, Inc.,announced today that leading research institutions, ... at the University of,Queensland, and the Biotech ... University of Copenhagen have recently purchased access ...
... 2008 /Xinhua-PRNewswire-FirstCall/ -- China YCT,International Group Inc. (OTC ... subsidiary, Shandong Spring Pharmaceutical Co., Ltd, has,entered into ... Tang,Bioengineering Co. Ltd., effective as of April 4, ... manage the operations of,Shandong Yong Chun Tang, in ...
Cached Biology Technology:Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland 2Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland 3China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier 2China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier 3
(Date:3/2/2015)... --  Neurotechnology , a provider of high-precision biometric, robotics ... Development Kit (SDK). The SentiGaze algorithm enables designers ... to track eye movements and generate heatmaps based on ... be used for applications such as analysis of websites ... can also be used to develop interfaces for a ...
(Date:2/24/2015)... 2015 Research and Markets ( ... "Global 2D Gesture Recognition Market 2015-2019" ... analysts forecast the Global 2D Gesture Recognition market ... the period 2014-2019 The increased demand ... one of the major trends in the market. ...
(Date:2/13/2015)... , Feb. 13, 2015 ACT Genomics ... that aims to transform cancer genomic information into ... the company has raised US$ 8 million in the ... in Taipei, Taiwan , ACT ... ACTOnco™. With the aim to implement next generation ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2ACT Genomics Raises $8 Million in its First Private Funding Round 2
... University of Florida researchers provides details on the first cookiecutter ... summer waters attract more people to the ocean. The ... of Pacific Science warns that swimmers entering the ... prey. The sharks feed near the surface at ...
... discovered flammable gas could be produced from rotting organic matter ... laws are pushing governments to use that ancient knowledge to ... biogas for energy. Our environment would be the winner since ... sites. However, while the scientific theory is simple, treating ...
... German . A musculoskeletal system so far unknown ... of Trigonopterus oblongus does not consist of the usual ... biological screw thread is about half a millimeter in size and ... by the current issue of the Science magazine. ...
Cached Biology News:New study documents first cookiecutter shark attack on a live human 2New study documents first cookiecutter shark attack on a live human 3Time to make more out of waste 2Time to make more out of waste 3Karlsruhe Institute of Technology: Nature uses screws and nuts 2
Mouse monoclonal [1C6/2] to Rad17 ( Abpromise for all tested applications). entrezGeneID: 5884 SwissProtID: Q9UPF5...
MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). &bul...
... Mucin 3 (MUC3) is a glycoprotein. ... a lesser extent in breast, lung and ... shows no cross-reaction with MUC1 and MUC2. ... human MUC3 Immunogen: MUC3 tandem ...
... bottoms,• Nonreversible lids with ... contamination,• Individual alphanumerical codes ... footprint for ease in ... cell attachment,• Sterilized by ...
Biology Products: